Tatva Chintan Pharma Chem Limited Total Assets
Tatva Chintan Pharma Chem Limited total assets. Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) holds total assets worth Rs9.08 Billion INR (≈ $98.17 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see TATVA market cap for the company's overall valuation and market capitalisation.
Total Assets of Tatva Chintan Pharma Chem Limited (2018–2025)
Total assets of Tatva Chintan Pharma Chem Limited from 2018 to 2025. This chart illustrates how Tatva Chintan Pharma Chem Limited's total assets have evolved over time, based on quarterly financial data. See Tatva Chintan Pharma Chem Limited stock quote for real-time trading data and today's change.
Tatva Chintan Pharma Chem Limited - Asset Composition Analysis
Tatva Chintan Pharma Chem Limited Total Assets Breakdown (March 2025)
Tatva Chintan Pharma Chem Limited total assets breakdown as of March 2025. Tatva Chintan Pharma Chem Limited's total assets of Rs9.08 Billion consist of 31.7% current assets and 68.3% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 1.4% |
| Accounts Receivable | Rs827.64 Million | 9.9% |
| Inventory | Rs1.34 Billion | 16.0% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs58.99 Million | 0.7% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Tatva Chintan Pharma Chem Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Tatva Chintan Pharma Chem Limited to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tatva Chintan Pharma Chem Limited's current assets represent 31.7% of total assets in 2025, a decrease from 53.0% in 2018.
- Cash Position: Cash and equivalents constituted 1.4% of total assets in 2025, down from 5.4% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 16.0% of total assets.
Tatva Chintan Pharma Chem Limited Competitors by Total Assets
Key competitors of Tatva Chintan Pharma Chem Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel NV
AS:AKZA
|
Netherlands | €13.95 Billion |
|
MITSU.CH.GRP ADR/5
F:M3C0
|
Germany | €5.88 Trillion |
|
LB Group Co Ltd
SHE:002601
|
China | CN¥63.89 Billion |
|
Hubei Feilihua Quartz Glass Co Ltd
SHE:300395
|
China | CN¥8.17 Billion |
|
Beijing Oriental Yuhong Waterproof Technology Co Ltd
SHE:002271
|
China | CN¥43.20 Billion |
|
Luxi Chemical Group Co Ltd
SHE:000830
|
China | CN¥35.95 Billion |
|
5N Plus Inc.
TO:VNP
|
Canada | CA$519.27 Million |
|
Zhejiang Runtu Co Ltd
SHE:002440
|
China | CN¥11.83 Billion |
Tatva Chintan Pharma Chem Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 3.69 | 1.59 |
| Quick Ratio | 0.99 | 1.56 | 0.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs1.44 Billion | Rs1.82 Billion | Rs570.52 Million |
Tatva Chintan Pharma Chem Limited - Advanced Valuation Insights
This section examines the relationship between Tatva Chintan Pharma Chem Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.67 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 2.1% |
| Total Assets | Rs8.36 Billion |
| Market Capitalization | $427.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tatva Chintan Pharma Chem Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Tatva Chintan Pharma Chem Limited's assets grew by 2.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Tatva Chintan Pharma Chem Limited (2018–2025)
The table below shows the annual total assets of Tatva Chintan Pharma Chem Limited from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs8.36 Billion ≈ $90.44 Million |
+2.14% |
| 2024-03-31 | Rs8.19 Billion ≈ $88.54 Million |
+8.25% |
| 2023-03-31 | Rs7.56 Billion ≈ $81.79 Million |
+14.89% |
| 2022-03-31 | Rs6.58 Billion ≈ $71.19 Million |
+109.12% |
| 2021-03-31 | Rs3.15 Billion ≈ $34.04 Million |
+26.46% |
| 2020-03-31 | Rs2.49 Billion ≈ $26.92 Million |
+32.76% |
| 2019-03-31 | Rs1.88 Billion ≈ $20.28 Million |
+29.85% |
| 2018-03-31 | Rs1.44 Billion ≈ $15.62 Million |
-- |
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more